"Although the principle of hormonal male contraception has been established and the method works, I do not believe that enough men would take hormones over many years", the current President of the German Society of Andrology, the urologist Wolfgang Weidner, was recently quoted by a German newspaper. He underlined his pessimistic opinion with the fact that none of the 250 abstracts submitted to the 7th European Congress of Andrology 2012 deals with male contraception [1]. An unnamed representative of USAID, which has a long record of supporting male contraception research, was heard saying "This is the kiss of death for hormonal male contraception", referring to the suspension of the large-scale WHO/CONRAD efficacy trial, and-also referring to this trial-Farid Saad, a research representative of Schering-Bayer which has a long tradition in contraception research and even male contraception research, concluded his talk on "Acceptability of hormonal male contraception by the pharmaceutical industry and the consumer" at the 15th International and 13th European Congress of Endocrinology in Florence 2012 by stating "None of the big companies will touch hormonal male contraception again".
展开▼
